BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 9689959)

  • 1. [Dosimetry methods in determining radiation dosage of the rectum in HDR-brachytherapy of cervix carcinoma].
    Eich HT; Haverkamp U; Micke O; Prott FJ; Pötter R
    Strahlenther Onkol; 1998 Jul; 174(7):375-80. PubMed ID: 9689959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dosimetric analysis at ICRU reference points in HDR-brachytherapy of cervical carcinoma.
    Eich HT; Haverkamp U; Micke O; Prott FJ; Müller RP
    Rontgenpraxis; 2000; 53(2):62-6. PubMed ID: 10994367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Definitive radiotherapy based on HDR brachytherapy with iridium 192 in uterine cervix carcinoma: report on the Vienna University Hospital findings (1993-1997) compared to the preceding period in the context of ICRU 38 recommendations.
    Pötter R; Knocke TH; Fellner C; Baldass M; Reinthaller A; Kucera H
    Cancer Radiother; 2000; 4(2):159-72. PubMed ID: 10812362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer in brachytherapy with specific attention to some quality assurance aspects.
    Fellner C; Pötter R; Knocke TH; Wambersie A
    Radiother Oncol; 2001 Jan; 58(1):53-62. PubMed ID: 11165682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
    Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
    Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
    Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
    Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
    Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A dosimetric comparison between applicators used for brachytherapy in carcinoma cervix - A single-institute prospective study.
    Suryadevara A; Kumar MV; Vasundhara E; Alluri KR; Ahamed S; Guduru S
    Indian J Cancer; 2018; 55(3):230-232. PubMed ID: 30693884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CT-based 3D dose-volume parameter of the rectum and late rectal complication in patients with cervical cancer treated with high-dose-rate intracavitary brachytherapy.
    Kato S; Tran DN; Ohno T; Nakano T; Kiyohara H; Ohkubo Y; Kamada T
    J Radiat Res; 2010; 51(2):215-21. PubMed ID: 20339256
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bladder and rectum dose defined from MRI based treatment planning for cervix cancer brachytherapy: comparison of dose-volume histograms for organ contours and organ wall, comparison with ICRU rectum and bladder reference point.
    Wachter-Gerstner N; Wachter S; Reinstadler E; Fellner C; Knocke TH; Wambersie A; Pötter R
    Radiother Oncol; 2003 Sep; 68(3):269-76. PubMed ID: 13129634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique role of proximal rectal dose in late rectal complications for patients with cervical cancer undergoing high-dose-rate intracavitary brachytherapy.
    Cheng JC; Peng LC; Chen YH; Huang DY; Wu JK; Jian JJ
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1010-8. PubMed ID: 14575832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survey of the use of the ICRU 38 in recording and reporting cervical cancer brachytherapy.
    Pötter R; Van Limbergen E; Gerstner N; Wambersie A
    Radiother Oncol; 2001 Jan; 58(1):11-8. PubMed ID: 11165676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Image-guided cervix high-dose-rate brachytherapy treatment planning: does custom computed tomography planning for each insertion provide better conformal avoidance of organs at risk?
    Davidson MT; Yuen J; D'Souza DP; Batchelar DL
    Brachytherapy; 2008; 7(1):37-42. PubMed ID: 18299111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors for predicting rectal dose of high-dose-rate intracavitary brachytherapy after pelvic irradiation in patients with cervical cancer: a retrospective study with radiography-based dosimetry.
    Huang EY; Wang CJ; Lan JH; Chen HC; Fang FM; Hsu HC; Huang YJ; Wang CY; Wang YM
    Int J Radiat Oncol Biol Phys; 2010 Feb; 76(2):490-5. PubMed ID: 19467795
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetry of intracavitary placements for uterine and cervical carcinoma: results of orthogonal film, TLD, and CT-assisted techniques.
    Kapp KS; Stuecklschweiger GF; Kapp DS; Hackl AG
    Radiother Oncol; 1992 Jul; 24(3):137-46. PubMed ID: 1410567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additional rectal and sigmoid mucosal points and doses in high dose rate intracavitary brachytherapy for carcinoma cervix: a dosimetric study.
    Mahantshetty U; Tiwana MS; Jamema S; Mishra S; Engineer R; Deshpande D; Shrivastava S
    J Cancer Res Ther; 2011; 7(3):298-303. PubMed ID: 22044811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Problems in reporting doses and volumes during multiple high-dose-rate intracavitary brachytherapy for carcinoma cervix as per ICRU Report 38: a comparative study using flexible and rigid applicators.
    Datta NR; Basu R; Das KJ; Rajasekar D; Pandey CM; Ayyagari S
    Gynecol Oncol; 2003 Nov; 91(2):285-92. PubMed ID: 14599857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implications of applicators orientations on bladder, and rectal doses in gynecological mHDR brachytherapy: A retrospective analysis of reproducibility in multi-fractionated regimen.
    Srivastava AK; Rastogi M; Mishra SP
    J Cancer Res Ther; 2019; 15(6):1345-1351. PubMed ID: 31898671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis.
    Clark BG; Souhami L; Roman TN; Evans MD; Pla C
    Int J Radiat Oncol Biol Phys; 1994 Mar; 28(5):1243-50. PubMed ID: 8175412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
    Kim RY; Shen S; Duan J
    Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.